Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients

NCT00382044 · clinicaltrials.gov ↗

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Kidney Failure, Chronic
Anemia

Interventions

DRUG: Eprex; Neorecormon; Aranesp

Sponsor

Sir Charles Gairdner Hospital